Mereo commences Phase IIb trial of BPS-804 to treat OI

UK-based biopharmaceutical firm Mereo BioPharma has commenced the Phase IIb ASTEROID clinical trial of BPS-804 to treat patients with osteogenesis imperfecta (OI).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news